NCT06505837 2025-08-28
JS001sc or JS001 Plus Chemotherapy is Indicated for Relapsed or Metastatic First-Line Non-Squamous Non Small Cell Lung Cancer（NSCLC）
Shanghai Junshi Bioscience Co., Ltd.
Phase 3 Active not recruiting
Clinical Trials
1 trialsRecurrent Metastatic Non-Squamous Non Small Cell Lung Cancer × Injections, Subcutaneous × 1 year × Clear all